Supplementary Table 2 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma

Supplementary Table 2 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma

<p>Supplementary Table 2</p>

Saved in:

Bibliographic Details
Main Author:	Hirohito Ishigaki (19206165) (author)
Other Authors:	Takayoshi Yamauchi (14858253) (author), Mark D. Long (14858244) (author), Toshifumi Hoki (19206168) (author), Yuta Yamamoto (9172043) (author), Takaaki Oba (14858250) (author), Fumito Ito (14858274) (author)
Published:	2025
Subjects:	Cancer Immuno-oncology Skin Cancers Melanoma Immunology Tumor resistance to immune response T cell exhaustion
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Figure 1 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2025)

Figure 2 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2025)

Figure 3 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2025)

Figure 4 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2025)

Supplementary Table 3 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2025)

Supplementary Table 2 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2024)

Supplementary Table 3 from Generation, Transcriptomic States, and Clinical Relevance of CX3CR1<sup>+</sup> CD8 T Cells in Melanoma
by: Hirohito Ishigaki (19206165)
Published: (2024)

Supplementary Tables from Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma
by: Donagh Egan (16426514)
Published: (2025)

Supplementary Figure 1 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Supplementary Figure 2 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Supplementary Figure 3 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Supplementary Figure 4 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Supplementary Figure 5 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Supplementary Figure 6 from Cytotoxic CD8<sup>+</sup> T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma That Drives Antitumor Immunity
by: Karine Flem-Karlsen (15073449)
Published: (2025)

Figure 1 from Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
by: J. Jason Morton (22673303)
Published: (2025)

Figure 2 from Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
by: J. Jason Morton (22673303)
Published: (2025)

Figure 3 from Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
by: J. Jason Morton (22673303)
Published: (2025)

Figure 4 from Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
by: J. Jason Morton (22673303)
Published: (2025)

Figure 5 from Autologous Thymic Organoids Support Functional T-cell Education and Enhance Antitumor Immunity in Humanized Mice with Melanoma Xenografts
by: J. Jason Morton (22673303)
Published: (2025)

Figure S1 from The Spatial Organization of cDC1 with CD8<sup>+</sup> T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
by: Elisa Gobbini (20982732)
Published: (2025)

Figure S2 from The Spatial Organization of cDC1 with CD8<sup>+</sup> T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
by: Elisa Gobbini (20982732)
Published: (2025)

Figure S3 from The Spatial Organization of cDC1 with CD8<sup>+</sup> T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma
by: Elisa Gobbini (20982732)
Published: (2025)

Table S2 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8<sup>+</sup> T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
by: Kelly M. Mahuron (21351938)
Published: (2025)

Table S3 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8<sup>+</sup> T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
by: Kelly M. Mahuron (21351938)
Published: (2025)

Table S4 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8<sup>+</sup> T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
by: Kelly M. Mahuron (21351938)
Published: (2025)

Table S5 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8<sup>+</sup> T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
by: Kelly M. Mahuron (21351938)
Published: (2025)

Table S6 from Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8<sup>+</sup> T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma
by: Kelly M. Mahuron (21351938)
Published: (2025)

Supplementary Table S1 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4<sup>+</sup> T Cells
by: Signe Caksa (16745174)
Published: (2025)

Supplementary Table S2 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4<sup>+</sup> T Cells
by: Signe Caksa (16745174)
Published: (2025)

Supplementary Table S3 from Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4<sup>+</sup> T Cells
by: Signe Caksa (16745174)
Published: (2025)

CD38CD39 Population DEGs DS1 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
by: Ankita Mitra (17141783)
Published: (2025)

Teee Gene Signature DS2 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
by: Ankita Mitra (17141783)
Published: (2025)

Teee vs Treg Clusters DEGs DS3 from A Population of Tumor-Infiltrating CD4<sup>+</sup> T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
by: Ankita Mitra (17141783)
Published: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
by: Hansol Lee (15054787)
Published: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
by: Hansol Lee (15054787)
Published: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
by: Hansol Lee (15054787)
Published: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
by: Hansol Lee (15054787)
Published: (2025)

Table S1 from Blocking CX3CR1<sup>+</sup> Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
by: Xiaonan Xiang (20103716)
Published: (2024)

Table S2 from Blocking CX3CR1<sup>+</sup> Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
by: Xiaonan Xiang (20103716)
Published: (2024)

Table S3 from Blocking CX3CR1<sup>+</sup> Tumor-Associated Macrophages Enhances the Efficacy of Anti-PD1 Therapy in Hepatocellular Carcinoma
by: Xiaonan Xiang (20103716)
Published: (2024)

Cannot write session to /tmp/vufind_sessions/sess_d6kb33gf143stvqtai6nh659qs